跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
FERRIPROX MR - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
FERRIPROX MR
Authorized
STANDARD
FERRIPROX MR
chiesi canada corp.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
7c4095d018875a43
Company
chiesi canada corp.
Type
Standard
Approval Details
Approval Id
7c4095d018875a43
Drug Approval Canada Name
FERRIPROX MR
Product Name
FERRIPROX MR
Status
Marketed
Status Date
2023-06-05
Original Market Date
2023-06-05
Din
02536579
Drug Class
Human
Dosage Form
Tablet (Extended-Release)
Route Of Administration
Oral
Schedule
Prescription
Ahfs
64:00.00
Atc Original
V03AC02 DEFERIPRONE
Atc Name
v 03 ac 02
Aig Number
0156430003
Company Name
chiesi canada corp.
Company Address
100e-3800 Steeles Avenue West, Woodbridge, Ontario, Canada, L4L 4G9
Active Ingredients
DEFERIPRONE
1000 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
7c4095d018875a43
Type
Standard
Back to Health Canada Approvals